(3,4-dihydroxyphenylamino)-2-imidazoline has been researched along with Innate Inflammatory Response in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dinarello, CA; Joosten, LA; Kullberg, BJ; Netea, MG; Smeekens, SP; van de Veerdonk, FL; van der Meer, JW | 1 |
1 other study(ies) available for (3,4-dihydroxyphenylamino)-2-imidazoline and Innate Inflammatory Response
Article | Year |
---|---|
Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease.
Topics: Blotting, Western; Caspase 1; Catecholamines; Cytokines; Gene Expression Regulation; Granulomatous Disease, Chronic; Humans; Imidazolines; Inflammation; Interleukin-1beta; Monocytes; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric | 2010 |